Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Finasteride [For B.P.H.]). Same strength and form. Confirm the switch with your doctor or pharmacist.
Indications & Uses
Pronor is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
The recommended dosage is one 5 mg tablet daily. Although early improvement may be seen, treatment for at least six months may be necessary to assess whether a beneficial response has been achieved. Thereafter, treatment should be continued.
Side Effects
Pronor is well tolerated. In clinical studies, the following adverse experiences have been reported as possibly drug related in 1% of patients treated for 12 months with 5 mg Pronor daily: impotence (3.7%), decreased libido (3.3%), and decreased volume of ejaculate (2.8%).
Cautions & Contraindications
Warnings & Precautions
General: Since the beneficial response to Pronor may not be manifested immediately, patients with large residual urine volume and/or severely diminished urinary flow should be carefully monitored for obstructive uropathy.Prostate cancer: Digital rectal examination, as well as, other evaluations for prostate cancer, should be performed on patients with BPH prior to initiating therapy with Pronor and periodically thereafter. Pronor causes a decrease in serum concentration of markers of prostatic cancer such as prostate specific antigen (PSA); therefore, reduction of serum levels of these markers in patients with BPH treated with Pronor does not rule out concomitant prostate cancer. No clinical benefit has yet been demonstrated in patients with prostate cancer treated with Pronor.
Contraindications
Hypersensitivity to any component of this medication. Finasteride use is also contraindicated in women and paediatric patient